The global symptomatic treatment (anti-inflammatory drugs, antihistamines, others) celiac disease treatment market size was valued at US$ 170.5 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2030.